Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NUDT1 | P36639 | 1/20 | 0.36 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22402408 | 0.77 | NUDT1 (0.33) | NUDT1 | |
| SCHEMBL22402413 | 0.77 | NUDT1 (0.36) | NUDT1HTT | |
| SCHEMBL22693062 | 0.75 | HTT (0.41) | SLC2A1HTTPTK2 | |
| SCHEMBL22402409 | 0.74 | NUDT1 (0.39) | NUDT1 | |
| SCHEMBL22402410 | 0.71 | CDK2 (0.38) | NUDT1 | |
| SCHEMBL22402415 | 0.65 | SLC2A1 (0.33) | NUDT1SLC2A1 | |
| SCHEMBL22402406 | 0.64 | TRPV1 (0.41) | NUDT1PTK2 | |
| SCHEMBL22941856 | 0.62 | DYRK1A (0.36) | SLC2A1HTTPTK2 | |
| SCHEMBL13660393 | 0.61 | SMN1; SMN2 (0.38) | HTT | |
| SCHEMBL19661001 | 0.60 | HTT (0.44) | SLC2A1HTTPTK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200283424-A1 | GLP-1R AGONISTS AND USES THEREOF | QILU REGOR THERAPEUTICS INC. (CN) | 2020-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200283424-A1 | GLP-1R AGONISTS AND USES THEREOF | GLP1R, GPR119, GIPR | NUDT1 3409/4885SLC2A1 168/4885HTT 3952/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.